Clostridium butyricum produces the postbiotic butyrate which stimulates GLP-1. Bifidobacterium infantis produces the postbiotic acetate, and interacts with Akkermansia and Butyricum to promote an ecosystem in the gut that naturally boosts GLP-1
Eli Lilly markets the only FDA-approved GIP/GLP-1 dual agonist, tirzepatide, and also offers a GLP-1-selective option in dulaglutide
Werner syndrome: Clinical features, pathogenesis and potential therapeutic interventions
At Revital Trichology & Wellness , we utilize evidence-based peptide therapies under medical supervision to support healthy aging, metabolic health, tissue repair, cognitive function, body composition, and overall longevity
Macro Foods strategically integrates ingredients that promote GLP-1 activation, enhancing weight loss efforts